samedan logo
 
 
spacer
home > pmps > autumn 2020 > medication adherence for the modern covid world
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Medication Adherence for the Modern COVID World

According to a survey by the Pharmaceutical Research and Manufacturers of America, its members spent roughly $79.6 billion on R&D in 2018 (1). That amount would make it the 70th largest country in terms of GDP. It’s well known that many of the compounds and drugs that make up that figure never go to market. However, even those that do, don’t always achieve their full potential, simply because patients don’t use them as directed.

The issue of medication adherence has been long discussed among the healthcare industry. Research shows one in four patients never pick up a prescription, and roughly half fail to take their medication as directed (2). The many health issues plaguing the population certainly can’t be attributed to medication adherence, but its impact, to some degree, is undeniable.

Like any widespread issue, the nuances of medication adherence are seemingly endless. However, by examining subsets of this problem, such as vulnerable populations and proven efficacious strategies, there is progress to made.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Thomas Grinnan is Vice President, Sales and Marketing, Healthcare at Silgan Dispensing Systems. He has worked in the pharmaceutical industry for more than 28 years as an Executive, Innovator, Consultant, and Business Development Specialist. He began his career in strategic consulting, working closely with pharma and medical device companies and leveraging his university training in biological sciences. After a long career at Westvaco, MeadWestvaco, and Westrock’s Healthcare and Patient Adherence packaging divisions, Thomas joined Silgan Dispensing Systems, a spin-off specialising in liquid dispensing solutions for nasal, topical, and ophthalmic delivery. He resides in Richmond, US, but has worked and lived in Europe often throughout his career.
spacer
Thomas Grinnan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

OWEN MUMFORD LAUNCHES NEW 2-STEP SINGLE-USE AUTO-INJECTOR PLATFORM AIDAPTUS®

OXFORD, England, 22nd September - Owen Mumford Pharmaceutical Services, a division of Owen Mumford Ltd. has launched its new Aidaptus® auto-injector platform following successful completion of development.
More info >>

White Papers

Financial implications of off-site visits in clinical research, perception versus reality

Illingworth Research

The concept of patient centricity is still relatively new within clinical trials. For too long, the most important person in the trial has been overlooked… the patient. Here, we explore the benefits of conducting a more patient-centric trial for the patient, site and sponsor through mobile, or ‘off-site’ visits. These advantages are much greater than purely financial, although the financial implications of running a more patient-focused clinical trial may previously have deterred some from this approach. Home nursing in clinical trials continues to be thought of as a high value “premium” service, which many sponsors decline in an attempt to remain within budget for the trial. However, is the actual cost of off-site nursing more expensive than the traditional site model?
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement